KRISTIN DAMIANO: Open Payments
NPI 1902574353 · GAINESVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,511 in 79 payments from 15 companies in 2025. Trend: 2023 $36 · 2024 $0 · 2025 $1,511
Food & beverage: $1,412Education: $98
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $364 |
| Janssen Biotech, Inc. | 14 | $320 |
| GENZYME CORPORATION | 8 | $172 |
| Regeneron Healthcare Solutions, Inc. | 3 | $151 |
| Novartis Pharmaceuticals Corporation | 5 | $119 |
| Galderma Laboratories, L.P. | 4 | $72 |
| Organon LLC | 3 | $60 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $54 |
| UCB, Inc. | 2 | $49 |
| E.R. Squibb & Sons, L.L.C. | 2 | $39 |
Products named: TREMFYA, DUPIXENT, SKYRIZI, RINVOQ, COSENTYX, ILUMYA, Bimzelx, Sotyktu.
Industry payments across GA — which companies pay providers there.
